What Is Menopause? The Complete Guide to Stages, Symptoms and Treatment
What Is Menopause? The Biological Definition
Menopause is the point when a woman has gone 12 consecutive months without a menstrual period. That single sentence sounds simple, but the biology behind it is anything but. The ovaries stop releasing eggs, estrogen production drops by roughly 60 percent, and the entire endocrine system recalibrates. The average age for natural menopause in the United States is 51, according to the North American Menopause Society. Most women hit it between 45 and 55. But the process leading up to that date — and the years that follow — vary wildly from one woman to the next.
What most people miss is that menopause is not a switch that flips overnight. It is a metabolic transition that plays out over years. The ovaries do not suddenly shut down. They slow production gradually, sometimes with dramatic surges and crashes along the way. That volatility is what produces the symptoms most women recognise: hot flashes, night sweats, brain fog, and mood swings. Understanding which stage you are in determines what treatments actually work.
The Three Stages of Menopause
Doctors divide the menopause transition into three distinct phases: perimenopause, menopause, and postmenopause. Each has a different hormonal profile, a different symptom set, and different treatment windows.
Perimenopause — The Transition That Lasts Years
Perimenopause begins when the ovaries start making less estrogen. For most women, this starts in their mid-40s, but some notice changes as early as 35. The average duration is four years, according to a 2023 study from the University of Michigan tracking 1,200 women across five states. But it can last anywhere from a few months to a decade. Periods become irregular — longer cycles, shorter cycles, heavier bleeding, lighter bleeding. Hot flashes often start here, and sleep quality begins to deteriorate before a woman even connects the dots.
This is also the stage where pregnancy is still possible. Irregular ovulation means cycles are unpredictable, not absent. OB/GYN Dr. Mary Jane Minkin, a clinical professor at Yale School of Medicine, points out that many women in their late 40s assume they cannot get pregnant because their periods are sporadic. They can. About 10 percent of pregnancies in women over 40 happen during perimenopause.
Menopause — The One-Day Milestone
Strictly speaking, menopause is a single day: the date 12 months after a woman’s last period. Nothing special happens that day. It is a retrospective diagnosis. You do not know you have reached menopause until a full year has passed without bleeding. During this window, estrogen has dropped to its lowest sustained level, and symptoms typically peak in severity.
The 2025 Australian Women’s Midlife Years (AMY) Study, published in The Lancet Diabetes & Endocrinology, surveyed 10,500 women across Australia and found that nearly 40 percent of perimenopausal women had moderate to severe vasomotor symptoms that went completely untreated. Vasomotor symptoms — hot flashes and night sweats — are the hallmark complaint at this stage. For roughly 25 percent of women, these symptoms are severe enough to disrupt daily functioning.
Postmenopause — The Rest of Your Life
Postmenopause covers every year after that 12-month marker. Symptoms do not vanish. A 2024 study in the journal Menopause followed 3,200 women for 10 years and found that 30 percent still reported hot flashes a decade after their last period. The difference is that the hormonal rollercoaster settles. Estrogen stays low and stable rather than surging and crashing. That stability means mood swings and irregular bleeding stop, but the long-term risks shift. Bone density drops faster, cardiovascular risk rises, and vaginal tissues thin.
Common Symptoms and What They Actually Feel Like
The official list of menopause-related symptoms runs to 34 distinct items, according to the International Menopause Society. The most common ones cluster into a few categories.
hot flashes are the headline symptom. They feel like a sudden wave of heat rising from the chest to the face, often followed by sweating and chills. They last anywhere from 30 seconds to 10 minutes. About 75 percent of women experience them during the transition, according to the Study of Women’s Health Across the Nation (SWAN), a multi-site longitudinal study that has tracked over 3,300 women since 1996. For some women, hot flashes are a minor nuisance. For others, they strike 20 times a day and wreck sleep entirely.
Night sweats are hot flashes that happen during sleep. They drench sheets, disrupt deep sleep cycles, and leave women waking up exhausted regardless of how many hours they stayed in bed. The resulting sleep debt amplifies every other symptom — irritability, poor concentration, low energy.
Vaginal dryness and atrophy affect more than half of postmenopausal women. The tissues of the vagina become thinner, drier, and less elastic because estrogen fuels their maintenance. Intercourse becomes painful. Urinary urgency and recurrent UTIs also spike in this group, since the same tissue loss affects the urethra.
Brain fog — difficulty concentrating, memory lapses, losing words mid-sentence — is one of the most-reported but least-studied symptoms. A 2024 review in Neuroscience & Biobehavioral Reviews concluded that estrogen fluctuations disrupt working memory and verbal fluency, particularly during perimenopause, because estrogen receptors in the hippocampus depend on stable hormonal input.
Hormone Therapy: What the 2025 Research Says
Hormone therapy (HT) — also called menopausal hormone therapy (MHT) — replaces the estrogen your ovaries stop making. It is the single most effective treatment for moderate to severe vasomotor symptoms. No drug or supplement comes close in trial data. The evidence base is decades deep, but the interpretation has shifted significantly since 2022.
A comprehensive review published in the International Journal of Molecular Sciences in November 2025 synthesised findings from over 80 studies and concluded that MHT reduces hot flash frequency by 75 to 90 percent when initiated within 10 years of menopause onset. The review also found that modern low-dose, transdermal estrogen patches carry a lower risk of blood clots than the high-dose oral formulations used in the original Women’s Health Initiative (WHI) trials of the early 2000s.
This is where the trade-off lives. The 2025 FDA Expert Panel on Menopause and Hormone Therapy, convened in July 2025, reaffirmed that MHT is appropriate for symptomatic women under 60 or within 10 years of menopause. For women over 60 or more than a decade past menopause, the panel noted that the cardiovascular risk profile shifts. The benefit-to-risk ratio narrows. The panel did not say “no HT ever” for older women. It said doctors need to justify the decision with a clear clinical reason and documented discussions with the patient.
A 2025 nationwide Danish register study in The BMJ tracked over 400,000 women and found no increase in all-cause mortality among MHT users compared with non-users over a 10-year follow-up period. That is a direct contradiction of the fear-based messaging that followed the 2002 WHI partial results. Dr. JoAnn Manson, lead investigator of the WHI and professor at Harvard Medical School, has stated publicly that the WHI was misrepresented in the media and that for most women under 60, the benefits of HT for symptom management outweigh the risks.
Nonhormonal Treatment Options That Work
Not every woman can or wants to take hormones. Breast cancer survivors, women with a history of blood clots, and those with unexplained vaginal bleeding need alternatives. Until recently, the options were limited to lifestyle adjustments and off-label antidepressants. That changed in 2023 with the FDA approval of fezolinetant (brand name Veozah), the first drug designed specifically for hot flashes that is not a hormone.
Fezolinetant works by blocking neurokinin B, a brain chemical that plays a role in heat regulation. A phase 3 trial published in The Lancet in 2023 showed that women taking 45 mg of fezolinetant once daily experienced a 60 percent reduction in moderate to severe hot flashes by week 12, compared with a 22 percent reduction in the placebo group. In 2025, the FDA approved a second drug in the same class, elinzanetant (Lynkuet), which targets both neurokinin B and another receptor involved in sleep regulation.
SSRIs and SNRIs — antidepressants like paroxetine (Paxil) and venlafaxine (Effexor) — remain effective second-line options. A 2024 meta-analysis from the Cochrane Collaboration reviewed 24 trials and found that low-dose paroxetine reduced hot flash frequency by about 40 percent. The limitation is side effects: nausea, dizziness, and sexual dysfunction are common enough that about 15 percent of women discontinue within the first three months.
Vaginal estrogen is a separate category. It is a low-dose topical treatment — cream, tablet, or ring — that delivers estrogen directly to vaginal tissues without significant systemic absorption. It treats vaginal dryness, painful intercourse, and recurrent UTIs without the clotting risk associated with oral estrogen. The American College of Obstetricians and Gynecologists considers it safe for breast cancer survivors after consultation with their oncologist.
Lifestyle Changes That Make a Real Difference
Lifestyle interventions are not a substitute for medical treatment when symptoms are severe, but they reduce symptom burden enough that every woman should know what works and what does not.
Weight matters more than most women realise. Fat tissue produces its own estrogen through a process called aromatisation. More body fat means more circulating estrogen, even after the ovaries stop. That sounds helpful, but the trade-off is that excess body fat increases breast cancer risk and worsens hot flashes in some women. A 2024 review in the Journal of Clinical Endocrinology & Metabolism analysed 15 studies and concluded that women with a BMI over 30 were 2.5 times more likely to report severe hot flashes compared with women in the normal BMI range. The mechanism is not fully understood, but the data is consistent across populations.
Exercise — specifically resistance training and moderate cardio — preserves bone density and improves mood. The recommended dose is 150 minutes of moderate activity per week, per the U.S. Department of Health and Human Services. Weight-bearing exercise like walking, jogging, or lifting weights slows bone loss. A 2023 study from the University of Jyväskylä in Finland found that women who did 30 minutes of resistance training three times a week maintained lumbar spine bone density over 18 months, while the control group lost 2.3 percent.
Dietary changes have a real but limited effect. Phytoestrogens — compounds in soy, flaxseed, and legumes that weakly mimic estrogen — reduce hot flash frequency by about 20 percent in some studies, but results are inconsistent. A 2024 systematic review in Nutrients found that 10 of 17 trials showed a benefit from soy isoflavones, while 7 showed no difference from placebo. The evidence does not support relying on soy alone, but adding it to a balanced diet is harmless and may help.
When to See a Doctor and What to Ask
Most women go through early perimenopause without medical help. But there are clear thresholds where waiting makes no sense. The North American Menopause Society gives specific criteria for when to book an appointment:
- Symptoms that disrupt sleep, work, or relationships
- Periods that are very heavy or spaced less than 21 days apart
- Bleeding after a full year without a period — this requires immediate evaluation because it can signal endometrial cancer
- Vaginal dryness that makes sex painful
- Mood swings or depression that coincide with changes in your cycle
For women in their 40s, a blood test measuring follicle-stimulating hormone (FSH) can confirm perimenopause, but it is not always necessary. The standard diagnostic criterion remains clinical: irregular periods plus typical symptoms in a woman aged 45 or older. Below 40, FSH testing is warranted because early menopause — also called primary ovarian insufficiency — requires different management. About 1 percent of women go through menopause before age 40, and for them, hormone replacement is not optional. It is standard of care to protect bone and heart health.
When you walk into the exam room, be direct. Do not ask “Could this be menopause?” Ask “I have these specific symptoms, here is how they affect my life, what treatments have the best data for my profile?” Bring a list of what you have tried. If your doctor dismisses your symptoms without offering options, find a menopause specialist through the NAMS certified practitioner directory. The gap between evidence and practice is still wide. A 2025 survey in Frontiers in Global Women’s Health of 2,800 women across five countries found that fewer than 1 in 3 women who sought help for menopause symptoms received a treatment plan that addressed their primary complaint within the first two appointments. You do not have to accept that.